Cahill Represents Initial Purchasers in $1.5 Billion Notes Offerings for Bausch Health Companies Inc. and Bausch Health Americas, Inc.
Date: 03/08/19
Cahill represented the initial purchasers in connection with Rule 144A offerings of (i) $500,000,000 aggregate principal amount of 5.750% senior secured notes due 2027 by Bausch Health Companies Inc. and (ii) $1,000,000,000 aggregate principal amount of 8.500% senior notes due 2027 by Bausch Health Americas, Inc. Bausch Health Companies Inc. is a multinational specialty pharmaceutical company. Proceeds from the offerings were used to fund tender offers and pay related fees, premiums and expenses.